{"id":1912,"date":"2025-05-12T16:33:58","date_gmt":"2025-05-12T07:33:58","guid":{"rendered":"https:\/\/www.lifescience.shokubai.co.jp\/?post_type=news&#038;p=1912"},"modified":"2025-05-12T16:34:06","modified_gmt":"2025-05-12T07:34:06","slug":"nippon-shokubai-to-exhibit-at-tides-usa-2025","status":"publish","type":"news","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/","title":{"rendered":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d"},"content":{"rendered":"\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"975\" height=\"156\" src=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/04\/923bc6d36ab885472af5a5d70d495a08.png\" alt=\"\" class=\"wp-image-1889\" srcset=\"https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/04\/923bc6d36ab885472af5a5d70d495a08.png 975w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/04\/923bc6d36ab885472af5a5d70d495a08-300x48.png 300w, https:\/\/www.lifescience.shokubai.co.jp\/home\/wp-content\/uploads\/2025\/04\/923bc6d36ab885472af5a5d70d495a08-768x123.png 768w\" sizes=\"auto, (max-width: 975px) 100vw, 975px\" \/><\/figure>\n\n\n\n<div style=\"height:42px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">Nippon Shokubai is going to exhibit at \u201c<a href=\"https:\/\/informaconnect.com\/tides\/\" target=\"_blank\" rel=\"noopener\" title=\"\">TIDES USA 2025<\/a>\u201d.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.<br>We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory research to clinical trials, thereby contributing to the development of therapeutic technologies in disease areas with low treatment satisfaction.<br>We look forward to meeting you at the exhibition and having fruitful discussions.<\/p>\n\n\n\n<div style=\"height:35px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<p class=\"wp-block-paragraph\">\u3010Date\u3011May 19th \u2013 22<sup>nd<\/sup>, 2025<br>\u3010Place\u3011Manchester Grand Hyatt San Diego, San Diego, CA, USA<br>\u3010Our booth\u3011<a href=\"https:\/\/tidesus2025.expofp.com\/\" target=\"_blank\" rel=\"noopener\" title=\"\">712, Level1<\/a><br>\u3010Our title in the Exhibition\u3011<br>\u3000Comprehensive oligonucleotide and peptide APIs solutions with Nippon Shokubai.<br>\u3010How to attend\u3011<br>\u3000TIDES USA 2025 offers several passes. Please visit the <a href=\"https:\/\/informaconnect.com\/tides\/\" target=\"_blank\" rel=\"noopener\" title=\"\">official website<\/a> and register.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u3010Our contact info.\u3011<br>\u3000NIPPON SHOKUBAI CO., LTD.<br>\u3000<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Health &amp; Medical Business Division<\/a><br>\u3000E-mail\uff1a<a href=\"mailto:health_medical@shokubai.co.jp\" target=\"_blank\" rel=\"noopener\" title=\"\">health_medical@shokubai.co.jp<\/a><\/p>\n","protected":false},"featured_media":0,"template":"","news_category":[15],"class_list":["post-1912","news","type-news","status-publish","hentry","news_category-event-en"],"acf":{"blank_url":"","pdf_url":null,"select_link":"single_link"},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.10 - aioseo.com -->\n\t<meta name=\"description\" content=\"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.10\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d | NIPPON SHOKUBAI\" \/>\n\t\t<meta property=\"og:description\" content=\"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-05-12T07:33:58+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-05-12T07:34:06+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d | NIPPON SHOKUBAI\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1912\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"position\":1,\"name\":\"\\u5bb6\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/#listItem\",\"name\":\"Event\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#listItem\",\"name\":\"\\u5bb6\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/#listItem\",\"position\":3,\"name\":\"Event\",\"item\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1912\\\/#listItem\",\"name\":\"Nippon Shokubai to Exhibit at \\u201cTIDES USA 2025\\u201d\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1912\\\/#listItem\",\"position\":4,\"name\":\"Nippon Shokubai to Exhibit at \\u201cTIDES USA 2025\\u201d\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news_category\\\/event-en\\\/#listItem\",\"name\":\"Event\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1912\\\/#webpage\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1912\\\/\",\"name\":\"Nippon Shokubai to Exhibit at \\u201cTIDES USA 2025\\u201d | NIPPON SHOKUBAI\",\"description\":\"Nippon Shokubai is going to exhibit at \\u201cTIDES USA 2025\\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/news\\\/1912\\\/#breadcrumblist\"},\"datePublished\":\"2025-05-12T16:33:58+09:00\",\"dateModified\":\"2025-05-12T16:34:06+09:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/\",\"name\":\"\\u682a\\u5f0f\\u4f1a\\u793e\\u65e5\\u672c\\u89e6\\u5a92\",\"description\":\"Nippon Shokubai\\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.lifescience.shokubai.co.jp\\\/en\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d | NIPPON SHOKUBAI","description":"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory","canonical_url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BreadcrumbList","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","position":1,"name":"\u5bb6","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","position":2,"name":"News","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/#listItem","name":"Event"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#listItem","name":"\u5bb6"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/#listItem","position":3,"name":"Event","item":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/#listItem","name":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/#listItem","position":4,"name":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d","previousItem":{"@type":"ListItem","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/#listItem","name":"Event"}}]},{"@type":"Organization","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"@type":"WebPage","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/#webpage","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/","name":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d | NIPPON SHOKUBAI","description":"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website"},"breadcrumb":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/#breadcrumblist"},"datePublished":"2025-05-12T16:33:58+09:00","dateModified":"2025-05-12T16:34:06+09:00"},{"@type":"WebSite","@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#website","url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/","name":"\u682a\u5f0f\u4f1a\u793e\u65e5\u672c\u89e6\u5a92","description":"Nippon Shokubai\u2019s Health & Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","inLanguage":"en-US","publisher":{"@id":"https:\/\/www.lifescience.shokubai.co.jp\/en\/#organization"}}]},"og:locale":"en_US","og:site_name":"NIPPON SHOKUBAI | Nippon Shokubai\u2019s Health &amp; Medical Business Division provides contract manufacturing (CDMO) of oligonucleotide and peptide APIs, process development, analytical development, and supports DDS research and drug discovery. We contribute to the next generation of drug modality with our technology.","og:type":"article","og:title":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d | NIPPON SHOKUBAI","og:description":"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory","og:url":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/","article:published_time":"2025-05-12T07:33:58+00:00","article:modified_time":"2025-05-12T07:34:06+00:00","twitter:card":"summary_large_image","twitter:title":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d | NIPPON SHOKUBAI","twitter:description":"Nippon Shokubai is going to exhibit at \u201cTIDES USA 2025\u201d. Oligonucleotides and peptides are new modalities that fill a gap caused by the limitations of small molecule and antibody drugs.We are providing solutions in oligonucleotide, peptide and DDS markets with a leading GMP system in Japan, proprietary technologies and a one-stop shop service from exploratory"},"aioseo_meta_data":{"post_id":"1912","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"WebPage","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-05-12 06:19:02","updated":"2025-06-28 07:55:08","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/\" title=\"\u5bb6\">\u5bb6<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/\" title=\"Event\">Event<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tNippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"\u5bb6","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/"},{"label":"News","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/"},{"label":"Event","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news_category\/event-en\/"},{"label":"Nippon Shokubai to Exhibit at \u201cTIDES USA 2025\u201d","link":"https:\/\/www.lifescience.shokubai.co.jp\/en\/news\/1912\/"}],"_links":{"self":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/1912","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":0,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news\/1912\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/media?parent=1912"}],"wp:term":[{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.lifescience.shokubai.co.jp\/en\/wp-json\/wp\/v2\/news_category?post=1912"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}